Note: Cephalon's revenues are gauged from an analysis of company filings.
Cephalon's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Cephalon Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Cephalon is developing and marketing.
Cephalon doesn't have any recent trademark applications, indicating Cephalon is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
VANTRELA ER (HYDROCODONE BITARTRATE) EXTENDED-RELEASE TABLETS Pharmaceutical preparations featuring hydrocodone bitartrate for the treatment of pain
VANTRELA ER ( HYDROCODONE BITARTRATE) EXTENDED-RELEASE TABLETS Pharmaceutical preparations featuring hydrocodone bitartrate for the treatment of pain
VELZETO Pharmaceutical preparations for the treatment of pain
Patent applications show Cephalon's intellectual property,
its current capabilities and future direction.
Cephalon has applied for 106 patents since 2009.
Cephalon's most recent patent was filed in March 2018 for Inhalation Systems, Devices And Methods.Digital systems, devices and methods for managing a drug therapy, such as an anti-IL5 mAb or anti-IL5 receptor mAb treatment regimen for patients suffering from severe asthma (e.g., eosinophilic asthma), are provided. The digital systems, devices and methods may include hardware and software for predicting patient responses to a long term anti-IL5 mAb or anti-IL5 receptor mAb treatment based on clinical data obtained following an initial treatment period.
Complete list of patent applications
Determine whether Cephalon grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Cephalon is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Competition: Cephalon vs. Largest Competitors
A competitive analysis shows these companies are in the same general field as Cephalon, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are in the same general field as Cephalon and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.